Ketamine induces apoptosis via the mitochondrial pathway in human lymphocytes and neuronal cells
Authors:
- N GazaNGN Gaza
- R WerdehausenRWR Werdehausen
- H HermannsHHH Hermanns
- I BauerIBI Bauer
- M.E. DurieuxMDM.E. Durieux
- M.W. HollmannMHM.W. Hollmann
- M.F. StevensMSM.F. Stevens
- 1 September 2010
- journal article
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 105 (3) , 347-354
Abstract
Ketamine has been shown to have neurotoxic properties, when administered neuraxially. The mechanism of this local toxicity is still unknown. Therefore, we investigated the mechanism of cytotoxicity in different human cell lines in vitro. We incubated the following cell types for 24 h with increasing concentrations of S(+)-ketamine and racemic ketamine: (i) human Jurkat T-lymphoma cells overexpressing the antiapoptotic B-cell lymphoma 2 protein, (ii) cells deficient of caspase-9, caspase-8, or Fas-associated protein with death domain and parental cells, and (iii) neuroblastoma cells (SHEP). N-Methyl-d-aspartate (NMDA) receptors and caspase-3 cleavage were identified by immunoblotting. Cell viability and apoptotic cell death were evaluated flowcytometrically by Annexin V and 7-aminoactinomycin D double staining. Mitochondrial metabolic activity and caspase-3 activation were measured. Ketamine, in a concentration-dependent manner, induced apoptosis in lymphocytes and neuroblastoma cell lines. Cell lines with alterations of the mitochondrial pathway of apoptosis were protected against ketamine-induced apoptosis, whereas alterations of the death receptor pathway did not reduce apoptosis. S(+)-Ketamine and racemic ketamine induced the same percentage of cell death in Jurkat cells, whereas in neuroblastoma cells, S(+)-ketamine was slightly less toxic. Ketamine at millimolar concentrations induces apoptosis via the mitochondrial pathway, independent of death receptor signalling. At higher concentrations necrosis is the predominant mechanism. Less toxicity of S(+)-ketamine was observed in neuroblastoma cells, but this difference was minor and therefore unlikely to be mediated via the NMDA receptor.Keywords
This publication has 26 references indexed in Scilit:
- Toxicology Profile of N -Methyl-d-aspartate Antagonists Delivered by Intrathecal Infusion in the Canine ModelAnesthesiology, 2008
- Lidocaine Induces Apoptosis via the Mitochondrial Pathway Independently of Death Receptor SignalingAnesthesiology, 2007
- Loss of Caspase-9 Provides Genetic Evidence for the Type I/II Concept of CD95-mediated ApoptosisJournal of Biological Chemistry, 2006
- Comparison of caudal ketamine with lidocaine or tramadol administration for postoperative analgesia of hypospadias surgery in childrenPediatric Anesthesia, 2006
- Combination Spinal Analgesic Chemotherapy: A Systematic ReviewAnesthesia & Analgesia, 2002
- Patient-controlled epidural analgesia with morphine or morphine plus ketamine for post-operative pain reliefEuropean Journal of Anaesthesiology, 1999
- Histological Findings After Long-Term Infusion of Intrathecal Ketamine for Chronic PainJournal of Pain and Symptom Management, 1999
- Adding Ketamine in a Multimodal Patient-Controlled Epidural Regimen Reduces Postoperative Pain and Analgesic ConsumptionAnesthesia & Analgesia, 1998
- Histopathology After Repeated Intrathecal Injections of Preservative-Free Ketamine in the RabbitAnesthesia & Analgesia, 1994
- Ketamine and Midazolam Neurotoxicity in the RabbitAnesthesiology, 1991